Trial · NCT00307333
Impact of Heart Rate Characteristics Monitoring in Neonates
NCT00307333, Not applicable, Completed, University of Virginia; results first posted 2013-05-17
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Impact of Heart Rate Characteristics Monitoring in Neonates. Trials, record NCT00307333. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00307333
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Impact of Heart Rate Characteristics Monitoring in Neonates
- NCT number
- NCT00307333
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 3,003 participants, actual
- Lead sponsor
- University of Virginia
- Conditions
- Sepsis
- Interventions
- HeRO heart rate characteristics monitor
- First posted
- 2006-03-27
- Last updated
- 2013-05-27
- Results first posted
- 2013-05-17
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Ventilator-free Days | 120 days | |
| Secondary | Duration of Hospital Stay | 120 days | |
| Secondary | Days on Antibiotics | 120 days | |
| Secondary | Mortality | 120 days |
Source ClinicalTrials.gov
Outcomes4
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Ventilator-free Days | 120 days | days | MEAN | |
| SECONDARY | Duration of Hospital Stay | 120 days | days | MEAN | |
| SECONDARY | Days on Antibiotics | 120 days | days | MEAN | |
| SECONDARY | Mortality | 120 days | participants | NUMBER |
Source ClinicalTrials.gov
Results by group8
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Ventilator-free Days | Intervention | 95.9 | Standard Deviation 35.1 | days | |
| Number of Ventilator-free Days | Control | 93.6 | Standard Deviation 37.8 | days | |
| Duration of Hospital Stay | Intervention | 59.6 | Standard Deviation 33.7 | days | |
| Duration of Hospital Stay | Control | 58.7 | Standard Deviation 34.5 | days | |
| Days on Antibiotics | Intervention | 15.7 | Standard Deviation 19.4 | days | |
| Days on Antibiotics | Control | 15.0 | Standard Deviation 19.1 | days | |
| Mortality | Intervention | 122 | participants | ||
| Mortality | Control | 152 | participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Intervention | 1,511 | |
| Overall Study | STARTED | Control | 1,492 | |
| Overall Study | COMPLETED | Intervention | 1,500 | |
| Overall Study | COMPLETED | Control | 1,489 | |
| Overall Study | NOT COMPLETED | Intervention | 11 | |
| Overall Study | NOT COMPLETED | Control | 3 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Mortality [120 days] | Investigations | Intervention | 122 | 1,500 | 122 |
| serious | Mortality [120 days] | Investigations | Control | 152 | 1,489 | 152 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Intervention | ||
| Total, all-cause mortality | Control | ||
| Total, other adverse events | Intervention | 0 | 1,500 |
| Total, other adverse events | Control | 0 | 1,489 |
| Total, serious adverse events | Intervention | 122 | 1,500 |
| Total, serious adverse events | Control | 152 | 1,489 |
Source ClinicalTrials.gov
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Intervention vs Control: Mortality | Trial comparisons |
| Intervention vs Control: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00307333
GET https://conductscience.org/api/trials/v1/NCT00307333/registered